首页> 外文会议>Annual meeting exposition of the Controlled Release Society >In Vitro and In Vivo Studies of Nanostructured Lipid Carrier for Acid Labile Drug
【24h】

In Vitro and In Vivo Studies of Nanostructured Lipid Carrier for Acid Labile Drug

机译:酸不稳定药物纳米结构脂质载体的体外和体内研究

获取原文

摘要

The aim of this study was to develop a nanostructured lipid carrier (NLC) for transdermal delivery of acid-labile drug. Stearylamine and glyceryl monostearate both lipids played important roles in the oil phase of NLC. Anionic sodium dodecyl sulfate in the water phase efficiently complexed with cationic stearylamine lipid and adsorbed on the lipid surface to protect NLC from aggregation. The best penetration enhancement concentration of enhancer isopropyl myristate was 3.75%. The drug transdermally delivered by NLC hydrogel was accumulated in the skin and continuously penetrated through the skin to maintain constant drug concentration in the blood at least 24 hours.
机译:这项研究的目的是开发用于酸不稳定药物的透皮递送的纳米结构脂质载体(NLC)。硬脂胺和单硬脂酸甘油酯在NLC的油相中都起着重要作用。水相中的阴离子十二烷基硫酸钠可与阳离子硬脂胺脂质有效地络合并吸附在脂质表面上,以保护NLC避免聚集。肉豆蔻酸异丙酯的最佳渗透增强浓度为3.75%。由NLC水凝胶透皮递送的药物积聚在皮肤中,并连续穿透皮肤,以保持血液中至少24小时的恒定药物浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号